Frontlight ResearchEarly access
Trial site
Accellacare - Winston-Salem
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Migraine1 trial
- Psoriasis1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- BioNTech SE1 trial
- Pfizer1 trial
- TriGemX Bio, Inc.1 trial
Running trials
Recruiting
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026